Yuling Li, a prominent leader in the biopharmaceutical sector, has been instrumental in advancing oncology treatments through her impactful work at CBT Pharmaceuticals. Her contributions in process development and manufacturing have not only driven the creation of revolutionary cancer therapies but also established her as a key figure in the biotechnology landscape. This article delves…